Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice

Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision

(2020) Hirokazu Kashiwagi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

(2019) David J. Kuter et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune Thrombocytopenia

(2019) Nichola Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations

(2019) F. Zaja et al.   BLOOD REVIEWS

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

(2017) Tomás José González-López et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years

(2016) Francesca Palandri et al.   AMERICAN JOURNAL OF HEMATOLOGY

TPO-RAs in pITP: description of a case series and analysis of predictive factors for response

(2016) Maria Gabriella Mazzucconi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Remissions after long-term use of romiplostim for immune thrombocytopenia

(2016) A. L. Marshall et al.   HAEMATOLOGICA

Advances in the pathophysiology of primary immune thrombocytopenia

(2016) María Perera et al.   Hematology

Long-term complications of splenectomy in adult immune thrombocytopenia

(2016) Lan-Huong Thai et al.   MEDICINE

Remissions after long-term use of romiplostim for immune thrombocytopenia

(2016) A. L. Marshall et al.   HAEMATOLOGICA

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

(2015) Tomás José González-López et al.   AMERICAN JOURNAL OF HEMATOLOGY

High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial

(2015) Y. Wei et al.   BLOOD

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

(2015) Adrian Newland et al.   BRITISH JOURNAL OF HAEMATOLOGY

Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults

(2015) Libor Červinek et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Can Immune Thrombocytopenia Be Cured with Medical Therapy?

(2015) Eline Prak et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study

(2014) Matthieu Mahévas et al.   BRITISH JOURNAL OF HAEMATOLOGY

Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients

(2014) Anil Kumar Tripathi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Romiplostim as early treatment for refractory primary immune thrombocytopenia

(2013) Anne Contis et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists

(2013) Bahareh Ghadaki et al.   TRANSFUSION

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years

(2012) N. Vianelli et al.   HAEMATOLOGICA

A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia

(2012) Y. TOMIYAMA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment

(2011) Giuseppe Tagariello et al.   BRITISH JOURNAL OF HAEMATOLOGY

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

(2011) Yukari Shirasugi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia

(2010) David J. Kuter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD